New #ESCGuidelines are out. Listen to EAPCIPresident Alaide Chieffo sharing the main take home messages from the new guidelines for the management of chronic coronary syndromes. Full document 👉 bit.ly/3XnsLKN Gianfranco Parati brings you the highlights from the new

CCS ESC guidelines now out. Starting with a very important - brand new - figure on classification

Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE. Read more in #EHJ academic.oup.com/eurheartj/adva… European Society of Cardiology European Society of Cardiology Journals #ESCCongress #CardioTwitter #tricuspidvalve

Great honor to have been a task member representing #EAPCi on CCS 2024 #ESCGuidelines and to share my main take home messages European Society of Cardiology EAPCIPresident

💥#ESCCongress Day 2️⃣💥 🎯Personalised TAVI care in severe AS. 🤝Joint session w/ Asian Pacific Society of Cardiology ⏰ 31 Aug // 8:15-9:15 📍 Global Stage ☉Dilated aorta & bicuspid aortic valve ☉Aortic stenosis w/ CAD ☉Small aortic annulus ☉Lifetime management of AS ESC President

💥#EAPCI at #ESCCongress Day 2️⃣💥 🎯European Society of Cardiology Guidelines for the Management of Chronic Coronary Syndromes ⏰ 31 Aug // 13:45-15:00 📍 London 🔸 Stepwise diagnostic approach 🔸 ANOCA/INOCA 🔸 Medical therapy 🔸 PCI or CABG Xavier Rosselló Professor Vijay Kunadian

💥#EAPCI at #ESCCongress Day 2️⃣💥 🔥 HOT LINE 3️⃣ ⏰ 31 Aug // 11:00-12:06 📍 London 🔸RESHAPE-HF2 🔸MATTERHORN 🔸Tri.Fr Marianna Adamo Gregg W. Stone MD Donal

The #EAPCI Core Curriculum for Percutaneous Valvular & Structural Heart Intervention Published in EuroIntervention on the occasion of #ESCCongress 2024 Significant work from the #EAPCI Training & Certification Committee and collaborators. bit.ly/3XowWGh

⏩️ EAPCI vision to organize and plan your interventional cardiology progress in percutaneous structural heart disease therapies 🔥 Thank you to all authors❗️ EAPCIPresident Profesor Dariusz Dudek - kardiolog Radoslaw Parma Eric Van Belle Giuseppe_Tarantini Dr. Nicolas M Van Mieghem PCRonline 🫀

Another positive signal for the use of TEER in FMR. It should be probably be considered early in this population alongside medications #ESC2024 #RESHAPEHF2

Encouraging RESHAPE-HF2 RCT #ESC2024 JACC Journals European Society of Cardiology M-TEER in SMR ⬇️HFH but not ☠️ in EF 20-30%. Aren’t we treating these pts already? RTHahnMD Sean Pinney DoctorKini Sahil Khera Lucy Noah Moss Anu Lala-Trindade Didier Tchetche thomas modine Univ.-Prof. Dr. Ralph Stephan von Bardeleben Philipp Lurz

💥#EAPCI at #ESCCongress Day 2️⃣💥 🔥 HOT LINE 5️⃣ ⏰ 31 Aug // 17:35-18:41 📍 London 🔸NOTION-3 🔸POPular PAUSE TAVI 🔸RHEIA George Dangas, MD, MACC, MSCAI ACTION

Landmark trials of #TAVI presented at #ESCCongress 2024 ❤️🇬🇧 #Cardiology #CathLab #cvVHD #vhdAS #TAVR #SAVR #OAC #PCI European Society of Cardiology #EAPCI

Landmark trials of #mitral and #tricuspid #TEER presented at #ESCCongress 2024 ❤️🇬🇧 #Cardiology #CardioTwitter #CathLab #cvVHD #vhdMR #vhdTR European Society of Cardiology Journals #EAPCI

💥#ESCCongress Day 3️⃣💥 🔥 HOT LINE 8️⃣ ⏰ 1 Sep // 16:15-17:21 📍 London 👉 SENIOR RITA 👉 EARTH-STEMI 👉 SCOFF Dr Roxana Mehran ESC President Robert Byrne Professor Vijay Kunadian Simone Biscaglia Gianluca Campo David Ferreira #EAPCI European Society of Cardiology

My main takeaway from RHEIA: The first ever RCT only including women sets the scene for TAVI being the default strategy in female<75 with severe AS🔥🔥! Better access, short hospital stay, faster recovery + excellent clinical and echo outcomes.

Gregorio Tersalvi Giuseppe Musumeci Federico Giacobbe Giacomo Maria Cioffi 🇨🇭🇮🇹🇨🇦 Aaysha Cader Alessandro Beneduce Valva Mitralis Alessandro Sticchi A.Nazmi Calik Maurizio taramasso Fabrizio Ugo, MD U. Annone MIЯVΛƬ #IC Giovanni Benfari FRANCESCO BURZOTTA

#ESCCongress European Society of Cardiology PCRonline 🫀 AVATAR 157 low-risk patients (mean age 67, 57% men, mean STS score 1.7%) randomly allocated to early SAVR group (n=78) or conservative treatment group (n=79) ITT analysis, after a median follow-up of 63 months, the primary composite endpoint

‼️Become an #EAPCI member NOW‼️ 🩺 Fast-track your professional development 📚 Level up your learning - access to the resources 🤝 Network with a diverse & inspirational #EAPCI community 🫵#YouAreEAPCI🫵 🔗 Join us 👉 bit.ly/3Plov7i #ESCCongress European Society of Cardiology

💥#ESCCongress Day 4️⃣💥 🔥 Coronary revascularisation in patients undergoing #TAVI: why? when? and how? ⏰ 2 Sep // 8:15-09:45 📍 Prague Martine Gilard Tanja Rudolph Chiara De Biase #EAPCI European Society of Cardiology